Biogen Inc. buy Truist Financial Co.
Start price
13.02.25
/
50%
€127.25
Target price
13.02.26
€202.02
Performance (%)
29.55%
End price
14.02.26
€164.85
Summary
This prediction ended on 14.02.26 with a price of €164.85. The prediction had a final performance of 29.55%. Truist_Financial_Co_ has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -7.266% | -7.266% | 27.107% |
| iShares Core DAX® | 2.489% | -5.941% | 2.896% |
| iShares Nasdaq 100 | 1.649% | -2.462% | 15.754% |
| iShares Nikkei 225® | 0.555% | -7.597% | 30.353% |
| iShares S&P 500 | 1.347% | -2.943% | 10.338% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Truist Financial Co. from $220.00 to $210.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten